P023 Clinical Dermatology in Aging People
DESCRIPTION
The number and proportion of people aged 60 years and older in the population is increasing. In 2019, the number of people aged 60 years and older was 1 billion. According the WHO this number will increase to 1.4 billion by 2030. Undoubtedly, dermatologists will be confronted with many more geriatric patients with diseases that are augmented by aging and even the presentation of new entities. In this session we will present facial changes in the mature patient as well as changes of the hair and nails, we will discuss autoimmune skin disease in mature patient as well as challenges in therapeutic approach in this age group.
LEARNING OBJECTIVES
Diagnose different dermatological conditions in mature patients
Evaluate all potential threats when choosing most appropriate therapy with special emphasis on the age of the patient.
Select the best treatment for each condition.
SCHEDULE
3:30 PM
Introduction
Branka Marinovic, MD, PhD, IFAAD
3:35 PM
Special factors to consider in elderly patients with psoriasis
Mark Lebwohl, MD, FAAD
4:00 PM
Autoimmune blistering diseases in elderly patients
Branka Marinovic, MD, PhD, IFAAD
4:20 PM
Q & A
Branka Marinovic, MD, PhD, IFAAD, Mark Lebwohl, MD, FAAD
4:35 PM
What happens with hair as we age
4:55 PM
Mastering systemic therapy in elderly patients
Carmen M Salavastru, MD, PhD, IFAAD
5:15 PM
Q & A
Carmen M Salavastru, MD, PhD, IFAAD
DIRECTOR
Branka Marinovic, MD, PhD, IFAAD
University Hospital Centre Zagreb; School of Medicine University of Zagreb
SPEAKERS
Mark Lebwohl, MD, FAAD
Natasha Atanaskova Mesinkovska, PhD, MD, FAAD
Carmen M Salavastru, MD, PhD, IFAAD
Carol Davila University of Medicine and Pharmacy, Colentina Clinical Hospital, Bucharest, Romania
DISCLOSURES
Mark Lebwohl, MD, FAAD
AbbVie – Consultant (1099 relationship)(Honoraria), Investigator(Grants/Research Funding); Added Health – Consultant (1099 relationship)(Honoraria); Aikium – Consultant (1099 relationship)(Honoraria); Almirall – Consultant(Honoraria); AltruBio Inc. – Consultant(Honoraria); Alumis – Consultant (1099 relationship)(Honoraria); Amgen – Consultant (1099 relationship)(Honoraria); Apogee Therapeutics – Consultant(Honoraria); Arcutis, Inc. – Consultant(Honoraria), Investigator(Grants/Research Funding); AstraZeneca – Consultant (1099 relationship)(Honoraria); Atomwise – Consultant(Honoraria); Avotres, Inc. – Consultant(Honoraria), Investigator(Grants/Research Funding); Bausch Health – Consultant (1099 relationship)(Honoraria); Boehringer Ingelheim – Consultant(Honoraria), Investigator(Grants/Research Funding); Bristol Myers Squibb – Investigator(Grants/Research Funding); Bristol-Myers Squibb – Consultant(Honoraria); Cara Therapeutics – Investigator(Grants/Research Funding); Castle Biosciences, Inc – Consultant(Honoraria); Celltrion – Consultant(Honoraria); Clexio Biosciences, Ltd – Investigator(Grants/Research Funding); CoreEvitas, LLC – Consultant(Honoraria); Dermavant Sciences – Consultant(Honoraria), Investigator(Grants/Research Funding); Dermsquared – Consultant (1099 relationship)(Honoraria); Edesa Biotech – Consultant (1099 relationship)(Honoraria); Eli Lilly – Consultant (1099 relationship)(Honoraria); Eli Lilly and Company – Investigator(Grants/Research Funding); Evommune, Inc. – Consultant(Honoraria); Facilitation of International Dermatology Education – Consultant(Honoraria); Forte Biosciences – Consultant(Honoraria); Galderma – Consultant(Honoraria); Genentech, Inc. – Consultant(Honoraria); Incyte Corporation – Consultant(Honoraria), Investigator(Grants/Research Funding); Inozyme Pharma – Investigator(Grants/Research Funding); J&J Innovative Medicine – Consultant (1099 relationship)(Honoraria); Janssen Research & Development, LLC – Investigator(Grants/Research Funding); Leo Pharma A/S – Consultant(Honoraria); Mayne Pharma Group – Consultant (1099 relationship)(Honoraria); Meiji Seika Pharma Co., Ltd – Consultant(Honoraria); Mindera – Consultant(Honoraria); Mirum Pharmaceuticals, Inc. – Consultant (1099 relationship)(Honoraria); MoonLake Immunotherapeutics – Consultant (1099 relationship)(Honoraria); New York College of Podiatric Medicine – Speaker/Faculty Education(Honoraria); Oruka Therapeutics – Consultant (1099 relationship)(Honoraria), Investigator(Grants/Research Funding); Pfizer Inc. – Consultant(Honoraria), Investigator(Grants/Research Funding); Revolo Therapeutics – Consultant (1099 relationship)(Honoraria); Sanofi/Regeneron – Consultant (1099 relationship)(Honoraria), Investigator(Grants/Research Funding); Seanergy Maritime Holdings Corp. – Consultant(Honoraria); Strata Skin Sciences – Consultant(Honoraria); Sun Pharmaceutical Industries Ltd. – Consultant (1099 relationship)(Honoraria); Takeda Pharmaceuticals USA Inc – Consultant (1099 relationship)(Honoraria); Teva Pharmaceutical Industries Ltd. – Consultant (1099 relationship)(Honoraria); Trevi Therapeutics – Consultant(Honoraria); UCB – Investigator(Grants/Research Funding); Verrica Pharmaceuticals Inc – Consultant(Honoraria);
Branka Marinovic, MD, PhD, IFAAD
No financial relationships exist with ineligible companies.
Natasha Atanaskova Mesinkovska, PhD, MD, FAAD
AbbVie – Investigator(No Compensation Received); Arcutis, Inc. – Investigator(No Compensation Received); Arena Pharmaceuticals – Advisory Board(Honoraria), Investigator(No Compensation Received); Concert Pharmaceuticals – Advisory Board(Honoraria); Eli Lilly – Speaker(Honoraria); Kyowa Hakko Kirin Pharma, Inc. – Investigator(No Compensation Received); La Roche-Posay Laboratorie Pharmaceutique – Advisory Board(Honoraria); Lilly ICOS LLC – Advisory Board(Honoraria), Investigator(No Compensation Received); Merz Aesthetics – Investigator(Grants/Research Funding); Nutrafol – Advisory Board(Honoraria); Pfizer Inc. – Advisory Board(Honoraria), Investigator(Grants/Research Funding);
Carmen M Salavastru, MD, PhD, IFAAD
Axel Springer AG – Other(Patent royalties or other compensation for Intellectual Property Rights); Ewopharma – Speaker(Honoraria); GENESIS PHARMA – Advisory Board(Fees); Reig Jofre – Advisory Board(Fees);